A Huge 30%-50% Revenue Boost For One Of My “Weird OTC Stocks”

A Follow Up To "Buy A Company Selling Land For Double the Market Cap"

I’m going to be giving an update to my readers on a stock I covered in one of the very first editions of “Weird OTC Stocks”. The company had recently released their 10-K and in it is an update on court proceedings that give the company another large catalyst for revenue growth in 2025. This court ruling involves the company’s ability to raise commission prices for the products that move through their facility. With this new price increase the company should be looking at a revenue increase in the range of $1.75 million to $2.0 million, a 30%-34% increase in the company’s total revenue as compared to their FY 2024 figures.

While the company is now actively collecting these price increases it is also exploring its legal possibilities of recourse to collect backpay on the increases it failed to collect while fighting this out in court. Should the company be able to collect this backpay owed to them it could boost their income for 2025 by an additional $1.1 million. That would increase the company’s total YOY sales figures by an additional 18% should they receive this money. On top of all of this new news, the company I am talking about is also still trying to sell off their businesses, which could result in a large dividend pay out and a total increase to shareholders’ value of around 45%.